Earnings call transcript: Affirm tops Q4 2026 estimates as profit jumps

Affirm reported fiscal Q4 2026 EPS of $4.62 vs. $0.85 expected (443.5% beat) and revenue of $1.17B vs. $1.11B expected (+5.4%). Management said it delivered its most profitable quarter ever (even excluding tax allowance releases) with consumer credit trends showing no delinquency stress and a favorable mix shift toward interest-bearing products. The stock rose 1.35% to $77.49 and jumped 8.34% after-hours to $83.95. For FY2027, revenue less transaction costs is guided to 4.16% vs. a historical midterm range of 3.25%–4%.

Analysis

AFRM’s message is less about a one-quarter beat and more about the business moving from a growth-at-all-costs profile to a tighter network model with real operating leverage. That matters for merchant partners and for funding counterparties: if credit can be held stable while mix shifts toward higher-margin products, the long-duration earnings power becomes more durable than the market has modeled, which should support multiple expansion if it persists into FY27.

The competitive read-through is harsher for weaker BNPL/flex-card players than for the card networks. A platform that can selectively loosen/tighten underwriting while still growing makes approval-rate competition a trap; rivals that chase share with easier approvals risk later loss creep. For banks like JPM, BAC, WFC and C, the upside is more limited but real: Edge-style partnerships are an option value channel for issuing/deposit relationships, though the earnings impact is more 6-18 months than immediate.

Key risk is that the market may overprice the cleanliness of the quarter. EPS can be distorted by ABS timing and tax mechanics, while the real tell is whether revenue less transaction costs stays above the new run-rate and whether credit remains benign as the product mix moves into in-store and larger baskets. If that metric slips back toward the old guide or delinquencies re-accelerate with a lag, the rerating can unwind quickly.

Contrarian view: the stock move is justified, but the consensus may still be underestimating the structural improvement in take rate and funding efficiency while overestimating how quickly the new initiatives monetize. The near-term setup favors momentum, but the better risk/reward is to buy on consolidation rather than chase the gap.

Key Decisions for Investors

• Long AFRM on any post-earnings pullback back into the high-$70s over the next 1-2 sessions; target a retest of $95-$100 over 1-3 months, with thesis invalidation on a close back below the pre-earnings close area if management commentary turns more cautious on credit or mix.
• Express upside with a 3-6 month AFRM 85/100 call spread instead of outright stock: defined risk if implied volatility stays elevated, while preserving participation if the market starts valuing FY27 profitability more like a durable network story.
• Do not force a long in V or the major banks off this print; any benefit to JPM/BAC/WFC/C is too second-order to drive standalone earnings revisions, so they are better watched than traded here unless Edge partnerships become material in the next 2-3 quarters.